TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm” or the “Company” or “CCS”), a leading global provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, and Virginia-based connected health provider Creo Wellness, LLC (“CREO”) confirm the companies have committed to integrate CardioComm’s ECG monitoring service technologies and ECG devices to support the CREO physician network’s management of patients and enhance the services offered through the CREO patient engagement platform.